Amodaia logo with green abstract symbol and white text on a light background | Amodaia
×

Market Access

Value Alone Isn’t Enough. You Need Strategy That Sticks.

We support access, pricing, and HEOR teams in building clear, evidence-based content that drives payer understanding, supports value demonstration, and enables reimbursement.

From global value stories to localised tools and submission-ready dossiers, we deliver content that aligns with market expectations and helps teams gain traction with HTA bodies and payers worldwide.

Three colleagues in conversation around a laptop at a high table in a modern office | Amodaia

Our Services Include:

  • Global and regional value proposition development
  • Cost-effectiveness and burden-of-illness evidence summaries
  • HTA strategy planning and workshop facilitation
  • AMCP dossiers, HTA briefing materials, and local objection handlers
  • Payer slide decks and evidence communication tools
  • Efficient localisation, evidence mapping, and comparator landscape scanning using validated workflows
All content is reviewed for payer relevance, scientific accuracy, and alignment with regional HTA expectations.

Case Studies

Biotech | EU – Market Access Payer Readiness for TED Biologic

Challenge: Global team preparing for payer discussions needed HEOR-aligned value messaging and practical workshop tools.

Solution: Developed a value framework, payer-salient messages, and interactive workshop materials grounded in patient insight and evidence.

Impact: Stronger internal alignment and more confident HTA conversations across regions.

Close up of laboratory pipette and microscope used for scientific research | Amodaia

Contact Details

Connect With Us

Contact Form

You need to fill up this field
You need to provide valid email address
You need to fill up this field
You need to fill up this text field
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Thank you for contacting us. One of our colleagues will get in touch with you soon.

Okay